Surgeon and Creative Writer. Interest:Education and the World, Ex Associate Professor RG Kar Medical College
Joined March 2019
- Tweets1.7K
- Following1.5K
- Followers396
- Likes19.9K
Samik Kumar Bandyopadhyay retweeted
Temporary venous bypass may facilitate complex pancreatic tumor resections with extensive vascular involvement, with mesoportal bypass favored when hepatic arterial resection is also required. ovid.com/10.1097/SLA.0000000…
Samik Kumar Bandyopadhyay retweeted
🔥#PANODE trial @DPCG_official published in @BjsOpen: what is the rate and survival impact of involved lymph node station (LNS) 16b1 (aortocaval)?
🔑 8-13% involved LNS16b1 ➡️ in 1218 Whipples for #PancreaticCancer and #perimapullary cancer
3-year overall survival + vs - LNS 16b1 pos:
❌ 5.2% vs 35% for PDAC
❌ 0% vs 45% for distal cholangioca
❌ 0% vs 61% for ampullary cancer
➡️ Future studies should assess routine preoperative and intraoperative sampling of LNS 16b1 and the impact of neoadjuvant treatment.
doi.org/10.1093/bjsopen/zrag…
Samik Kumar Bandyopadhyay retweeted
AI-generated 3D models of the liver, tumors, and blood vessels can help predict the complexity of liver resection before surgery. This approach may support more individualized surgical planning and referral to appropriate centers. ovid.com/10.1097/SLA.0000000…
Samik Kumar Bandyopadhyay retweeted
⏰ Deadline Approaching - E-AHPBA Scientific & Research Grants!
There's still time to apply for funding for your HPB research!
🔬 Up to €1,000 per project
👥 Open to current E-AHPBA members
📅 Application deadline: 10 November 2026
Don't miss this opportunity to advance your research and contribute to the future of HPB surgery!
Find out more and apply: eahpba.org/scientific-and-re…
#EAHPBA #HPB #SurgicalResearch #ResearchFunding
Samik Kumar Bandyopadhyay retweeted
📢 Just a few days to go until our next E-AHPBA Grand Rounds Webinar!
Join us this Thursday as we explore Hepatic Echinococcosis, featuring expert-led presentations followed by Q&A and discussion.
📅 Thursday 22 October 2026
🕕 18:00 CEST
💻 Free to attend | Open to all
There's still time to register!
🔗 Secure your place: eahpba.org/education-and-tra…
#EAHPBA #EAHPBAGrandRounds #HPBSurgery #HepaticEchinococcosis #SurgicalEducation
Samik Kumar Bandyopadhyay retweeted
How do BRAF and KRAS mutation status affect survival after cytoreductive surgery and HIPEC for CRC peritoneal metastaes? Find out in this month's #DCRJournal: bit.ly/4zBQRSw
Samik Kumar Bandyopadhyay retweeted
🔬 Take your laparoscopic liver surgery skills to the next level!
Join us for the E-AHPBA Lap Liver Masterclass, delivered in partnership with BOWA Medical and Corza Medical.
📅 10-11 December 2026
📍 BOWA Medical UK, Devon
🎟️ Places are limited - register today!
🔗 Register now: eahpba.org/education-and-tra…
#EAHPBA #LiverSurgery #LaparoscopicSurgery #SurgicalEducation
Samik Kumar Bandyopadhyay retweeted
Early data on VS-7375, @VerastemOncolog KRASG12D inhibitor in 2nd line and beyond #PancreaticCancer
50% ORR in 2nd line, 35% in 3rd/4th line
6mo OS of 80%
Proceeding with Phase 3 randomized trial in 1st line pancreatic (VS-7375 +EGFRi v VS-7375 + chemo)
investor.verastem.com/news-r…
Samik Kumar Bandyopadhyay retweeted
NGS of ctDNA for Precision Medicine in Advanced Biliary Tract Cancers
ClinicalCancerReseach
doi.org/10.1158/1078-0432.CC…
🔎10,937 pts
👉90% feasible vs 50% tissue
👉TAT 8 vs 27 days
👉83% ESCAT-I concordance
👉ctDNA prognostic: mOS 27.7 vs 13.6 mo
🧐ctDNA can expand access, accelerate precision medicine
@myESMO @EASLnews @ILCAnews
Samik Kumar Bandyopadhyay retweeted
Overview of the gastroduodenal artery.
onlinelibrary.wiley.com/doi/…
Samik Kumar Bandyopadhyay retweeted
Excellent nationwide collaboration @DPCG_official 🇳🇱 with training by international experts 🇺🇸🇩🇪
Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study
➡️ doi.org/10.1093/bjs/znag075
Nationwide implementation of the international best practice for LAPC was feasible with nearly three times more resections performed than expected, while morbidity and mortality remained well within predefined safety benchmarks
Work by Thomas F Stoop , Leonard W F Seelen , Freek R van ‘t Land , Jacobien C M Scheepens , Mahsoem Ali , Anna C van der Hout , B Marion van der Kolk , Bert A Bonsing , Daan J Lips , Eric R Manusama , François E J A Willemsen , Freek Daams , Geert Kazemier , Gijs A Patijn , Ignace H de Hingh , Jan H Wijsman , Jennifer Schreinemakers , Joris I Erdmann , J Sven D Mieog , Joost M Klaase , Judith A C Rietjens , Koop Bosscha , Lysanne P M Beuk , Maarten W Nijkamp , Marcel den Dulk , Marnix P M Kop , Mike S L Liem , Misha Luyer , Martijn W J Stommel , Olivier R Busch , Sebastiaan Festen , Stefan Bouwense , Tom M Karsten , Tom W van Ravens , Ulff P Neumann , Vincent E de Meijer , Vincent B Nieuwenhuijs , Werner A Draaisma , Wouter Derksen , Thomas L Bollen , Bas Groot Koerkamp , Casper H J van Eijck , I Quintus Molenaar , Christopher L Wolfgang , Marco Del Chiaro , Matthew H G Katz , Thilo Hackert , Johanna W Wilmink , Hjalmar C van Santvoort , Roeland F de Wilde , Marc G Besselink , the Dutch Pancreatic Cancer Group
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @PancreasClub #PancreasClub2023 #PancreaticCancer #Pancreatitis #HCC @PanCAN #PanCANawareness @EurPancClub @P_C_E_ @dice_europe #PancreaticCancer #cholangiocarcinoma #HPBSurgery #GallbladderCancer #Oncology #LiverSurgery
Samik Kumar Bandyopadhyay retweeted
KRAS, once considered undruggable in cancer, has finally become actionable. Read this cutting-edge review. bmjoncology.bmj.com/content/…
Samik Kumar Bandyopadhyay retweeted
Looking forward to joining the International HPB Surgery School tonight🇹🇷
From Asian guidelines to evolving concepts of borderline resectable HCC, I’ll share our perspectives on the changing landscape of HCC surgery🥦
See you there!
#HCC #LiverCancer #HPBSurgery
@NuhNRahbari
Samik Kumar Bandyopadhyay retweeted
🧭 International consensus set standards for EUS-guided choledochoduodenostomy with LAMS
🔸Preferred over percutaneous drainage after failed ERCP
🔸CBD ≥15 mm preferred
🔸Oral intake within 24h after uncomplicated procedures
📖 #OpenAccess 👉 bit.ly/4jlz1OG
ALT Visual abstract
Samik Kumar Bandyopadhyay retweeted
🦠 Gut microbiome composition is associated with response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma patients
New #GUTScience journal research by Halle-Smith et al. asks an important question: could the bacteria living in our gut be linked to how well pancreatic cancer responds to chemotherapy?
The researchers found differences in the gut microbiome of patients who responded differently to neoadjuvant chemotherapy. Some of the differences involved bacterial genes linked to how medicines are processed.
Why could this matter for clinicians and patients? 🩺
Pancreatic cancer can be difficult to treat, and patients can respond very differently to the same treatment. Understanding whether the gut microbiome is linked to treatment response could eventually help researchers develop better ways to predict — and potentially improve — how patients respond to therapy.
It is still too early to use the microbiome to guide individual treatment, but these findings add to growing evidence that the microbes living in our gut could be relevant to cancer care.
📖 Read the paper: bit.ly/4f6XRzg
#GUTScience #PancreaticCancer #CancerResearch #GutMicrobiome #Microbiome #Chemotherapy #PrecisionMedicine #TranslationalResearch @druppygill @Gut_BMJ @BMJOpen_Gastro @FrontGastro_BMJ
